Skip to content

The effect of PRP and CM in infertile women with poor ovarian response

The effects of intraovarian platelet rich plasma injection and conditioned medium on infertile women with poor ovarian response and ART outcomes

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240815062771N2
Enrollment
21
Registered
2025-02-04
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian failure to respond to ovarian stimulation. Other ovarian dysfunction

Interventions

Intervention 1: Intervention group: PRP extracted from the patients own blood sample. Intervention 2: Intervention group: Conditioned medium from mesenchymal stem cell culture. Intervention 3: Interve

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 42 Years

Inclusion criteria

Inclusion criteria: Three or fewer oocytes retrieved in at least one previous ovarian stimulation cycle and an abnormal ovarian reserve test or antral follicle count of less than five to seven or AMH <0.5–1.1 ng/mL Absence of fertility problems in the patient's husband

Exclusion criteria

Exclusion criteria: Ovarian failure due to gonadal dysgenesis and chromosomal abnormalities Immunoglobulin A deficiency History of major pelvic floor surgery that has resulted in severe pelvic adhesions. Use of anticoagulants Use of psychotropic drugs Presence of psychiatric disorders cancer History of chronic pelvic pain

Design outcomes

Primary

MeasureTime frame
Chemical Pregnancy. Timepoint: 15 days after embryo transfer. Method of measurement: Beta hCG blood test.;Definite clinical pregnancy. Timepoint: 30 days after embryo transfer. Method of measurement: Ultrasound visualization of the gestational sac or heartbeat.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahshad Khodarahmian

Tehran University of Medical Sciences

ma.khodarahmian@gmail.com+98 21 6649 2277

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026